37986103|t|m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling.
37986103|a|BACKGROUND: Liver metastasis is one of the most important reasons for high mortality of colorectal cancer (CRC). Growing evidence illustrates that lncRNAs play a critical role in CRC liver metastasis. Here we described a novel function and mechanisms of BACE1-AS promoting CRC liver metastasis. METHODS: qRT-PCR and in situ hybridization were performed to examine the BACE1-AS level in CRC. IGF2BP2 binding to m6A motifs in BACE1-AS was determined by RIP assay and S1m-tagged immunoprecipitation. Transwell assay and liver metastasis mice model experiments were performed to examine the metastasis capabilities of BACE1-AS knockout cells. Stemness-like properties was examined by tumor sphere assay and the expression of stemness biomarkers. Microarray data were acquired to analyze the signaling pathways involved in BACE1-AS promoting CRC metastasis. RESULTS: BACE1-AS is the most up-regulated in metastatic CRC associated with unfavorable prognosis. Sequence blast revealed two m6A motifs in BACE1-AS. IGF2BP2 binding to these two m6A motifs is required for BACE1-AS boost in metastatic CRC. m6A modified BACE1-AS drives CRC cells migration and invasion and liver metastasis both in vitro and in vivo. Moreover, BACE1-AS maintains the stemness-like properties of CRC cells. Mechanically, BACE1-AS promoted TUFT1 expression by ceRNA network through miR-214-3p. CRC patients with such ceRNA network suffer poorer prognosis than ceRNA-negative patients. Depletion of TUFT1 mimics BACE1-AS loss. BACE1-AS activated Wnt signaling pathway in a TUFT1 dependent manner. BACE1-AS/miR-214-3p/TUFT1/Wnt signaling regulatory axis is essential for CRC liver metastasis. Pharmacologic inhibition of Wnt signaling pathway repressed liver metastasis and stemness-like features in BACE1-AS over-expressed CRC cells. CONCLUSION: Our study demonstrated BACE1-AS as a novel target of IGF2BP2 through m6A modification. m6A modified BACE1-AS promotes CRC liver metastasis through TUFT1 dependent activation of Wnt signaling pathway. Thus, targeting BACE1-AS and its downstream Wnt signaling pathways may provide a new opportunity for metastatic CRC intervention and treatment.
37986103	0	3	m6A	Chemical	MESH:C005955
37986103	13	21	BACE1-AS	Gene	100379571
37986103	37	53	liver metastasis	Disease	MESH:D009362
37986103	86	103	colorectal cancer	Disease	MESH:D015179
37986103	112	117	TUFT1	Gene	7286
37986103	169	185	Liver metastasis	Disease	MESH:D009362
37986103	245	262	colorectal cancer	Disease	MESH:D015179
37986103	264	267	CRC	Disease	MESH:D015179
37986103	336	356	CRC liver metastasis	Disease	MESH:D015179
37986103	411	419	BACE1-AS	Gene	100379571
37986103	430	450	CRC liver metastasis	Disease	MESH:D015179
37986103	525	533	BACE1-AS	Gene	100379571
37986103	543	546	CRC	Disease	MESH:D015179
37986103	548	555	IGF2BP2	Gene	319765
37986103	567	570	m6A	Chemical	MESH:C005955
37986103	581	589	BACE1-AS	Gene	100379571
37986103	674	690	liver metastasis	Disease	MESH:D009362
37986103	744	754	metastasis	Disease	MESH:D009362
37986103	771	779	BACE1-AS	Gene	100379571
37986103	837	842	tumor	Disease	MESH:D009369
37986103	975	983	BACE1-AS	Gene	100379571
37986103	994	1008	CRC metastasis	Disease	MESH:D015179
37986103	1019	1027	BACE1-AS	Gene	100379571
37986103	1067	1070	CRC	Disease	MESH:D015179
37986103	1138	1141	m6A	Chemical	MESH:C005955
37986103	1152	1160	BACE1-AS	Gene	100379571
37986103	1162	1169	IGF2BP2	Gene	319765
37986103	1191	1194	m6A	Chemical	MESH:C005955
37986103	1218	1226	BACE1-AS	Gene	100379571
37986103	1247	1250	CRC	Disease	MESH:D015179
37986103	1252	1255	m6A	Chemical	MESH:C005955
37986103	1265	1273	BACE1-AS	Gene	100379571
37986103	1281	1284	CRC	Disease	MESH:D015179
37986103	1318	1334	liver metastasis	Disease	MESH:D009362
37986103	1372	1380	BACE1-AS	Gene	100379571
37986103	1423	1426	CRC	Disease	MESH:D015179
37986103	1448	1456	BACE1-AS	Gene	100379571
37986103	1466	1471	TUFT1	Gene	7286
37986103	1516	1518	3p	Chromosome	3
37986103	1520	1523	CRC	Disease	MESH:D015179
37986103	1624	1629	TUFT1	Gene	7286
37986103	1637	1645	BACE1-AS	Gene	100379571
37986103	1652	1660	BACE1-AS	Gene	100379571
37986103	1698	1703	TUFT1	Gene	7286
37986103	1722	1730	BACE1-AS	Gene	100379571
37986103	1742	1747	TUFT1	Gene	7286
37986103	1795	1815	CRC liver metastasis	Disease	MESH:D015179
37986103	1877	1893	liver metastasis	Disease	MESH:D009362
37986103	1924	1932	BACE1-AS	Gene	100379571
37986103	1948	1951	CRC	Disease	MESH:D015179
37986103	1994	2002	BACE1-AS	Gene	100379571
37986103	2024	2031	IGF2BP2	Gene	10644
37986103	2040	2043	m6A	Chemical	MESH:C005955
37986103	2058	2061	m6A	Chemical	MESH:C005955
37986103	2071	2079	BACE1-AS	Gene	100379571
37986103	2089	2109	CRC liver metastasis	Disease	MESH:D015179
37986103	2118	2123	TUFT1	Gene	7286
37986103	2187	2195	BACE1-AS	Gene	100379571
37986103	2283	2286	CRC	Disease	MESH:D015179
37986103	Association	MESH:C005955	MESH:D009362
37986103	Association	100379571	319765
37986103	Association	MESH:C005955	MESH:D015179
37986103	Bind	MESH:C005955	319765
37986103	Association	MESH:D015179	100379571
37986103	Association	MESH:D009362	7286
37986103	Association	MESH:C005955	7286
37986103	Positive_Correlation	100379571	7286
37986103	Association	MESH:D015179	7286
37986103	Association	MESH:D015179	319765
37986103	Association	MESH:D009362	100379571
37986103	Association	MESH:C005955	100379571

